Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Acceleron Pharma Inc. (XLRN)

« Back to company index

XLRN Chatter Timeline

Stock Ticker for XLRN

Most Active Tweeters for XLRN

UserTweets
@j_jccnidan 26
@Biotech2050 16
@Tickeron 12
@HealthcareBeat 10
@dakotafinancial 9

Recent Tweets for XLRN

HealthcareBeat @HealthcareBeat
New patent application published for: Isolated Gdf Trap Polypeptide $XLRN https://t.co/AY65BDkKnH
2:07pm
gcassidy718 @gcassidy718
$XLRN Major changes in stock price 5.27 % change recently https://t.co/Cjbv1BHC3y
10:07am
BlueBioNow @BlueBioNow
$XLRN might be worth taking a position when this bottoms 5.27 % change recently https://t.co/gR0MpM5fid
9:07am
WatchlistN @WatchlistN
ValuEngine Downgrades Acceleron Pharma $XLRN to Hold https://t.co/l5orfIP09s
8:07am
WatchlistN @WatchlistN
Acceleron Pharma $XLRN Downgraded by BidaskClub https://t.co/1Fj7D30bBp
8:07am
ConsumerFeed @ConsumerFeed
ValuEngine Downgrades Acceleron Pharma $XLRN to Hold https://t.co/aAWBZtJOBr
8:07am
dakotafinancial @dakotafinancial
ValuEngine Downgrades Acceleron Pharma $XLRN to Hold https://t.co/9oWD6AAV3a
8:07am
BlueBioNow @BlueBioNow
$XLRN this is the time you buy equities thank you fed 5.27 % change recently https://t.co/gR0MpM5fid
July 3rd 2020, 10:07pm
Tickeron @Tickeron
$XLRN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on June 19, 2020. View odds f… https://t.co/wrYIYMOkmx
July 3rd 2020, 1:07pm
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Downgraded by ValuEngine to “Hold” https://t.co/Tc3dpKNFEK
July 3rd 2020, 1:07pm
gcassidy718 @gcassidy718
$XLRN what a Company 5.27 % change recently https://t.co/Cjbv1BHC3y
July 3rd 2020, 7:07am
dakotafinancial @dakotafinancial
Acceleron Pharma $XLRN Rating Lowered to Hold at BidaskClub https://t.co/zZBKs3Lyrb
July 3rd 2020, 6:07am
ConsumerFeed @ConsumerFeed
Acceleron Pharma $XLRN Rating Lowered to Hold at BidaskClub https://t.co/WEWYYfxqQv
July 3rd 2020, 6:07am
OlympiaReport @OlympiaReport
Acceleron Pharma $XLRN Downgraded by BidaskClub to “Hold” https://t.co/EXZmnROiIU
July 2nd 2020, 4:07pm
WeekHerald @WeekHerald
Acceleron Pharma $XLRN Downgraded by BidaskClub to “Hold” https://t.co/Pnfh0tmzUJ
July 2nd 2020, 4:07pm
semodough @semodough
$XLRN 101 now - impressive strength after pretty big raise this week.
July 2nd 2020, 12:07pm
tradersreport @tradersreport
RT @Tickeron: $XLRN in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/u5j7Pm2Ubc #Ac…
July 2nd 2020, 12:07pm
Tickeron @Tickeron
$XLRN in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/qRdfgRXPYz
July 2nd 2020, 12:07pm
IPODave @IPODave
Letting more go from $XLRN SPO yesterday
July 2nd 2020, 11:07am
j_jccnidan @j_jccnidan
$XLRN Very Bullish https://t.co/REEVXqn78D
July 2nd 2020, 11:07am
fintel_io @fintel_io
$XLRN / Acceleron Pharma files form 8-K - Financial Statements and Exhibits, Other Events - FORM 8-K https://t.co/h5LdbEgu6i
July 2nd 2020, 6:07am
OlympiaReport @OlympiaReport
Research Analysts’ Recent Ratings Updates for Acceleron Pharma $XLRN https://t.co/3itJGJIVXi
July 1st 2020, 6:07pm
j_jccnidan @j_jccnidan
$XLRN Days traders pulling the puppet strings
July 1st 2020, 4:07pm
TradesClear @TradesClear
$XLRN HOD, here it goes... https://t.co/LKdsKYDIrn
July 1st 2020, 2:07pm
TradesClear @TradesClear
$XLRN daily chart, volume coming in at support https://t.co/wna2KIflrG
July 1st 2020, 2:07pm
TradesClear @TradesClear
$XLRN has potential to run into the close, heavy volume
July 1st 2020, 2:07pm
j_jccnidan @j_jccnidan
$XLRN Another try @ $98
July 1st 2020, 2:07pm
portefeuillefun @portefeuillefun
RT @RoccoLefkowitz: $CRSP now 78's from 72's premarket, $XLRN now 96's from 92's premarket. Offering dip in solid performers is still the m…
July 1st 2020, 12:07pm
Tickeron @Tickeron
$XLRN in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on June 19, 2020. View odds f… https://t.co/pQxd1iwmmx
July 1st 2020, 12:07pm
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $XLRN ... https://t.co/mnYaiRq1wk
July 1st 2020, 11:07am
stocknewstimes @stocknewstimes
Acceleron Pharma $XLRN Stock Rating Lowered by BidaskClub https://t.co/ntjf12BeI3
July 1st 2020, 11:07am
RoccoLefkowitz @RoccoLefkowitz
$CRSP now 78's from 72's premarket, $XLRN now 96's from 92's premarket. Offering dip in solid performers is still t… https://t.co/8CApq5ish3
July 1st 2020, 10:07am
IPODave @IPODave
SPOs: $XLRN still extending. Took off some size in $CHMA but will hold as its still undervalued
July 1st 2020, 10:07am
j_jccnidan @j_jccnidan
$XLRN GL everybody time to move on I hope all of you make as much as I did
July 1st 2020, 9:07am
IPODave @IPODave
$CHMA trading well off premarket lows, $XLRN - thought it would run better. Both SPOs
July 1st 2020, 9:07am
BankTheTrade @BankTheTrade
$XLRN(95.27) down 2.50 said Tuesday that it priced a public offering of 4,864,864 common shares at $92.50 per shar… https://t.co/UEjnnTYF9r
July 1st 2020, 7:07am
pnani456 @pnani456
RT @Briefingcom: $XLRN: Acceleron Pharma prices offering of 4,864,864 shares of common stock at $92.50 per share https://t.co/toDfhyZBwJ
July 1st 2020, 7:07am
Briefingcom @Briefingcom
$XLRN: Acceleron Pharma prices offering of 4,864,864 shares of common stock at $92.50 per share https://t.co/toDfhyZBwJ
July 1st 2020, 7:07am
HottestStockNow @HottestStockNow
$XLRN Prices public offering of 4,864,864 shares of its common stock at $92.50 per share #AcceleronPharma https://t.co/y46kxy2AK6
June 30th 2020, 8:06pm
Hall8Jack @Hall8Jack
RT @jeff_cranmer: $XLRN raises $450M on the heels of EMA approval of Reblozyl to treat transfusion-dependent anemia. FDA approved the thera…
June 30th 2020, 8:06pm
BioStocks @BioStocks
$XLRN 4.86M shares offering priced at $92.50
June 30th 2020, 7:06pm
j_jccnidan @j_jccnidan
$XLRN Not sure if this is good or bad.... Comments welcome thanks
June 30th 2020, 7:06pm
jeff_cranmer @jeff_cranmer
$XLRN raises $450M on the heels of EMA approval of Reblozyl to treat transfusion-dependent anemia. FDA approved the… https://t.co/Y062Je9uxN
June 30th 2020, 7:06pm
zbiotech @zbiotech
Acceleron Pharma 4.9M-share offering priced at $92.50/sh through JPMorgan, SVB Leerink and Cowen $XLRN
June 30th 2020, 7:06pm
DZalkowitz @DZalkowitz
Added $XLRN post secondary
June 30th 2020, 7:06pm
StuckInStock @StuckInStock
$XLRN prices public offering at 92.5$/share
June 30th 2020, 6:06pm
otcdynamics @otcdynamics
$XLRN Acceleron Announces Pricing of Public Offering of Common Stock https://t.co/sPFzRYITCu
June 30th 2020, 6:06pm
GrnBulls @GrnBulls
Acceleron Prices 4.8M Share Public Offering of Common Stock @ $92.50/Share $XLRN
June 30th 2020, 6:06pm
HealthcareBeat @HealthcareBeat
Acceleron Announces Pricing of Public Offering of Common Stock $XLRN https://t.co/6BI2U3ijYo
June 30th 2020, 6:06pm
sbwcws @sbwcws
Acceleron 4.86M share Secondary priced at $92.50 $XLRN
June 30th 2020, 6:06pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.